Meningococcal conjugate vaccination among adolescents aged 13-17 years, United States, 2007

Vaccine

Volumn 28, Issue 11, 2010, Pages 2350-2355

  Lu, Peng jun ^a   Jain, Nidhi ^a   Cohn, Amanda C ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Adolescent vaccination; Coverage; Meningococcal conjugate vaccine; Vaccination

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; WART VIRUS VACCINE;

ADOLESCENT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; CAUCASIAN; FEMALE; HISPANIC; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; AGED; ANIMALS; HUMANS; INTERVIEWS AS TOPIC; MALE; MENINGOCOCCAL VACCINES; UNITED STATES; VACCINATION; VACCINES, CONJUGATE;

EID: 77049083820     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.032     Document Type: Article

References (46)

1. World Health Organization. Wkly Epidemiol Rec 2001; 37:281-8.
2. Barrow R., and Miller E. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned. Expert Rev Vaccines 5 6 (2006) 851-857
3. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. 10th ed. (2008), Public Health Foundation, Washington, DC
4. Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 54 No. RR-7 (2005) 1-21
5. Edwards M.S., and Baker C.J. Complications and sequelae of meningococcal infections in children. J Pediatr 99 (1981) 540-545
6. Kirsch E.A., Barton R.P., Kitchen L., and Giroir B.P. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J 15 (1996) 967-979
7. Jackson L.A., Schuchat A., Reeves M.W., Wenger J.D., and Serogroup. C meningococcal outbreaks in the United States: an emerging threat. JAMA 273 (1995) 383-389
8. Brooks R.B., Woods C.W., and Rosenstein NE. Neisseria meningitidis outbreaks in the United States, 1994-2002 [abstract 289]. Abstracts of the 41st Annual Meeting of the Infectious Diseases Society of America. October 9-12, 2003, San Diego, CA (2003) 81-82
9. Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 49 RR-7 (2000) 1-10
10. Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients. Pediatrics 116 (2005) 496-505
11. Centers for Disease Control and Prevention (CDC). Revised recommendations of the Advisory Committee on Immunization Practices (ACIP) to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine. MMWR 56 31 (2007) 794-795
12. Smith P.J., Battaglia M.P., Huggins V.J., Hoaglin D.C., Rodén A., Khare M., et al. Overview of the sampling design and statistical methods used in the National Immunization Survey. Am J Prev Med 20 4 Suppl. (2001) 17-24
13. Smith P.J., Hoaglin D.C., Battaglia M.P., Khare M., and Barker L.E. Statistical methodology of the National Immunization Survey 1994-2002. Vital Health Statistics Series 2. Data Evaluation and Methods Research. No. 138 (2005), National Center for Health Statistics p. 1-55
14. Centers for Disease Control and Prevention (CDC). National vaccination coverage among adolescents aged 13-17 years-United States, 2006. MMWR 56 (2007) 885-888
15. Jain N., Singleton J.A., Montgomery M., and Skalland B. Determining accurate vaccination coverage rates for adolescents: an overview of the methodology used in the National Immunization Survey-Teen 2006. Public Health Reports 124 5 (2009) 642-651
16. Korn E.L., and Graubard B.I. Predictive margins (direct standardization). Analysis of health surveys (1999), John Wiley & Sons Inc., New York, NY p. 126-40
17. Nadel M.R., Shapiro J.A., Klabunde C.N., et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 142 (2005) 86-94
18. Centers for Disease Control and Prevention (CDC). Vaccination coverage among adolescents aged 13-17 years. MMWR 57 40 (2008) 1100-1103
19. Enger K.S., and Stokley S. Meningococcal conjugate vaccine uptake, measured by Michigan's immunization registry. J Adolesc Health 40 (2007) 398-404
20. Pasteur S. Statement regarding the availability of Menactra vaccine (July 2005). http://www.acha.org/sanofi_pasteur_7-19-05.pdf [accessed October 2008]
21. Centers for Disease Control and Prevention (CDC). Notice to readers: limited supply of meningococcal conjugate vaccine, recommendation to defer vaccination of persons aged 11-12 years. MMWR 55 20 (2006) 567-568
22. Centers for Disease Control and Prevention (CDC). Notice to readers: improved supply of meningococcal conjugate vaccine, recommendation to resume vaccination of children aged 11-12 years. MMWR 55 43 (2006) 1177
23. Centers for Disease Control and Prevention (CDC). National, state, and urban area vaccination coverage levels among children aged 19-35 months-United States, 1997. MMWR 47 26 (1998) 547-554
24. Centers for Disease Control and Prevention (CDC). Progress toward elimination of Haemophilus influenzae type b disease among infants and children-United States, 1987-1993. MMWR 43 08 (1994) 144-148
25. Centers for Disease Control and Prevention (CDC). Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule-United States, February 2006-May 2007. MMWR 57 15 (2008) 398-401
26. Wortley P.M., and Jain N. Influenza vaccination coverage among adults aged ≥50 years and pneumococcal vaccination coverage among adults aged ≥65 years-United States, 2002. MMWR 52 41 (2003) 987-992
27. Lu P.J., Singleton J.A., Rangel M.C., Wortley P.M., and Bridges C.B. Influenza vaccination trends among adults 65 years or older in the United States, 1989-2002. Arch Intern Med 165 (2005) 1849-1856
28. Egede L.E., and Zheng D. Racial/ethnic differences in influenza vaccination coverage in high-risk adults. Am J Public Health 93 (2003) 2074-2078
29. Wooten K.G., Luman E.T., and Barker L.E. Socioeconomic factors and persistent racial disparities in childhood vaccination. Am J Health Behav 31 July-August (4) (2007) 434-445
30. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2007. MMWR 57 35 (2008) 961-966
31. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2005. MMWR 55 36 (2006) 988-993
32. Rosenthal J., Rodewald L., McCauley M., Berman S., Irigoyen M., Sawyer M., et al. Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States. Pediatrics 113 April (4) (2004) e296-e302
33. Egede L.E. Association between number of physician visits and influenza vaccination coverage among diabetic adults with access to care. Diabetes Care 26 September (9) (2003) 2562-2567
34. Wood D.L. Increasing immunization coverage. Pediatrics 112 October (4) (2003) 993-996
35. National Vaccine Advisory Committee. Standards for child and adolescent immunization practices. Pediatrics 112 4 (2003) 958-963
36. Centers for Disease Control and Prevention (CDC). Recommended immunization schedules for persons aged 0-18 years-United States, 2008. MMWR 57 01 (2008) Q1-Q4
37. Smith P.J., Stevenson J., and Chu S.Y. Associations between childhood vaccination coverage, insurance type, and breaks in health insurance coverage. Pediatrics 117 June (6) (2006) 1972-1978
38. Centers for Disease Control and Prevention (CDC). Vaccines for children program. Available at: http://www.cdc.gov/vaccines/programs/vfc/ [accessed November 12, 2008].
39. Ching P.L. Evaluating accountability in the vaccines for children program: protecting a federal investment. Public Health Rep 122 November-December (6) (2007) 718-724
40. Centers for Disease Control and Prevention (CDC). Vaccination coverage among children in kindergarten-United States, 2006-07 school year. MMWR 56 32 (2007) 819-821
41. Centers for Disease Control and Prevention (CDC). Vaccination coverage among children entering school-United States, 2005-06 school year. MMWR 55 41 (2006) 1124-1126
42. Wilson T.R., Fishbein D.B., Ellis P.A., and Edlavitch S.A. The impact of a school entry law on adolescent immunization rates. J Adolesc Health 37 December (6) (2005) 511-516
43. Fogarty K.J., Massoudi M.S., Gallo W., Averhoff F.M., Yusuf H., and Fishbein D. Vaccine coverage levels after implementation of a middle school vaccination requirement, Florida, 1997-2000. Public Health Rep 119 March-April (2) (2004) 163-169
44. Jacobs R.J., and Meyerhoff A.S. Effect of middle school entry requirements on hepatitis B vaccination coverage. J Adolesc Health 34 May (5) (2004) 420-423
45. Centers for Disease Control and Prevention (CDC). Meningococcal conjugate vaccine 2007-2008 requirements for middle school, 2008. Available at: http://www2.cdc.gov/nip/schoolsurv/immunizationrqmts.htm.
46. Khare M., Singleton J.A., Wouhib A., and Jain N. Assessment of potential bias in the National Immunization Survey (NIS) from the increasing noncoverage of non-landline telephone households. Presented at 42nd national immunization conference (NIC). Atlanta, Georgia (2008)